Back

Earkart Completes US FDA Registration for Its Hearing Aids

Earkart secured active US FDA device listings across four hearing aid categories, including prescription and OTC hearing aids.

Earkart news: the Earkart logo over a photo related to hearing care

Key Takeaways

  • Earkart completed US FDA establishment registration, announced on November 18, 2026.
  • It holds active device listings across four hearing aid categories.
  • The categories are prescription, OTC, wireless prescription and wireless OTC hearing aids.
  • Earkart says registration and listing are not FDA approval or clearance.
  • Earkart said it plans to explore partnerships and distribution opportunities in the US.
Table of Contents 6 sections
  1. Earkart's US FDA registration at a glance
  2. Earkart makes hearing aids and remote hearing test equipment
  3. Earkart's management on the US milestone
  4. What Earkart says it plans for the US market
  5. Where Earkart stands after its FDA registration
  6. FAQs

Earkart Limited, an Indian hearing aid maker, has completed its US Food and Drug Administration (FDA) establishment registration and secured active medical device listings across four hearing aid categories. The company announced the step on November 18, 2026.

Earkart said its listed portfolio covers prescription hearing aids, over-the-counter (OTC) hearing aids, wireless prescription hearing aids and wireless OTC hearing aids. The company's release states that establishment registration and device listing are not FDA approval, clearance or endorsement, and that each product remains subject to FDA rules.

Earkart's US FDA registration at a glance

DetailValue
CompanyEarkart Limited
What it completedUS FDA establishment registration
Device listingsActive listings across four hearing aid categories
CategoriesPrescription, OTC, wireless prescription and wireless OTC hearing aids
AnnouncedNovember 18, 2026
Is it FDA approval?No, the company says registration and listing are not approval or clearance

Earkart makes hearing aids and remote hearing test equipment

Earkart develops, manufactures and distributes hearing aids and audiology equipment. Its products include behind-the-ear (BTE) and receiver-in-canal (RIC) hearing aids, along with Earkart OMNI, a machine for remote hearing tests. The company makes its hearing aids at a plant in Noida, Uttar Pradesh, and its Managing Director is Rohit Misra.

The company was incorporated in 2021. Its Rs 49.26 crore SME IPO, which included an offer for sale by promoter Rohit Misra, was priced at Rs 135 per share, and its shares listed on the BSE SME platform in October 2025.

WhenWhat happened
2021Earkart Limited is incorporated
September 25 to 29, 2025SME IPO of Rs 49.26 crore at Rs 135 per share is open for bids
October 3, 2025Shares list on the BSE SME platform
November 18, 2026Completes US FDA establishment registration with listings in four hearing aid categories

Earkart's management on the US milestone

"Completing our U.S. FDA establishment registration and securing active device listings across four hearing aid categories is an important milestone in Earkart's international growth journey."

Management, Earkart Limited

What Earkart says it plans for the US market

Earkart said it intends to offer its own branded hearing aids to US consumers at affordable prices. The company said it plans to explore partnerships, distribution opportunities and market-entry strategies in the US, using its own product development and manufacturing capabilities.

In its release, Earkart cited Emergen Research figures that put the US hearing aids market at $4.65 billion in 2026, growing to $9.57 billion by 2035 at an annual growth rate of 8.4%.

Where Earkart stands after its FDA registration

Earkart, a BSE SME listed hearing aid maker incorporated in 2021, now holds US FDA establishment registration and active device listings in four hearing aid categories. The company has said it plans to explore partnerships and distribution opportunities in the US.

More news

Join Us Add as preferred source
Share

Frequently Asked Questions

What is Earkart?

Earkart Limited is an Indian company that develops, manufactures and distributes hearing aids and audiology equipment.

What did Earkart announce?

Earkart announced on November 18, 2026 that it has completed its US FDA establishment registration and secured active device listings across four hearing aid categories.

Is Earkart's registration an FDA approval?

No, Earkart's release says US FDA establishment registration and device listing are not FDA approval, clearance, certification or endorsement.

How many hearing aid categories did Earkart list with the FDA?

Earkart secured active device listings across four hearing aid categories.

Which hearing aid categories are in Earkart's FDA listings?

Earkart's listings cover prescription, OTC, wireless prescription and wireless OTC hearing aids.

How does Earkart plan to enter the US market?

Earkart said it plans to explore partnerships, distribution opportunities and market-entry strategies in the US.

How does Earkart plan to price its hearing aids in the US?

Earkart said it intends to offer its branded hearing aids to US consumers at affordable prices.

How big is the US hearing aids market according to Earkart's release?

Earkart cited Emergen Research figures putting the US hearing aids market at $4.65 billion in 2026, growing to $9.57 billion by 2035.

What products does Earkart make?

Earkart makes BTE and RIC hearing aids and the Earkart OMNI machine for remote hearing tests.

Where does Earkart make its hearing aids?

Earkart makes its hearing aids at a manufacturing plant in Noida, Uttar Pradesh.

Who is Earkart's Managing Director?

Rohit Misra is the Managing Director of Earkart Limited.

Is Earkart a listed company?

Yes, Earkart listed on the BSE SME platform on October 3, 2025 after an SME IPO of Rs 49.26 crore at Rs 135 per share.

More in Startups